Navigation Links
Dr. Ritchie Shoemaker Pleased to Announce Second Physician Achieves Shoemaker Protocol Certification for Treating Chronic Inflammatory Response Syndrome
Date:4/19/2013

Pocomoke, MD (PRWEB) April 19, 2013

Continuing his quest to build a nationwide network of certified physicians able to effectively treat patients suffering from mold illness and other immune related sickness, Dr. Ritchie Shoemaker announced recently that a second physician has completed the training and testing required to achieve certification in the Shoemaker Protocol, the leading treatment method in the fight against Chronic Inflammatory Response Syndrome.

Mary Ackerley, M.D., M.D.H., ABIHM, of Tucson, Arizona, in addition to becoming the latest Shoemaker Protocol Certified Physician, is a Harvard and Johns Hopkins trained board certified psychiatrist, is nationally board certified in Integrative and Holistic Medicine, and is a graduate of the three year program at the American Medical College of Homeopathy. Dr. Ackerley is a member of the Arizona Homeopathic and Integrative Medical Association, and serves on the Board of Integrative and Homeopathic Medicine in the State of Arizona.

“I am proud to have another esteemed and well qualified doctor certified in the Shoemaker Protocol,” said Dr. Shoemaker. “Dr. Ackerley’s extensive background and training gives people in the west, suffering from Chronic Inflammatory Response Syndrome, a resource in their area qualified to help them - with the leading treatment for this debilitating illness.”

In addition to her classical medical training, Dr. Ackerley has traveled extensively, studying Tibetan healing and the relationship between mind, body, and spirit. She studied shamans while writing her Harvard thesis, and proved that cures produced by ‘energetic’ medicine create measurable changes in the neuroendocrine immune system. “She recognized early on the importance of bridging what is known in medicine, with what is unknown, using science to show the way.”

Dr. Ackerley has a particular interest in the symptoms of anxiety, fatigue, and depression that fail to respond to conventional treatment. She seeks to address the underlying cause of these conditions with an evaluation of hormonal imbalances, genetic mutations, chronic inflammation, and hidden infections, such as mold illness, Lyme disease, and viral infections.

“The number one question we’ve been asked on the Surviving Mold website since it launched in 2010, is ‘Is there a doctor in my area who can help me?’ Dr. Mary is another physician who is helping us say yes, there is.”

About Dr. Ritchie Shoemaker - Ritchie Shoemaker, MD, is an internationally recognized leader in education, patient care, and research in the field of biotoxin related illness, and has treated over 6,000 patients. Dr. Shoemaker has written numerous papers and eight books, including the widely read Surviving Mold, and Mold Warriors. He has appeared on Good Morning America, the BBC, the Australian Broadcasting System, the Discovery Health Channel, and has spoken to the House of Representatives and the US Senate. He continues to give lectures, attend conferences on biotoxin illness, and provide one on one training to physicians working toward the Shoemaker CIRS Protocol Certification.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10625379.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Ritchie Shoemaker Proudly Announces First Graduate of Shoemaker Protocol Certification Training
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
6. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
7. WuXi PharmaTech Announces Third-Quarter 2011 Results
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Spherix Announces Third Quarter Financial Results
10. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... BILLERICA, Massachusetts , 30. November 2016 ... und Technologieunternehmen, hat heute die Unterzeichnung einer ... gegeben. Diesen zufolge wird Evotec AG Screeningleistungen ... und shRNA-Bibliotheken bereitstellen. Der Zugriff auf diese ... Bereich Screening eröffnet einen schnelleren Weg zur ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule cocrystal ... the latest FDA guidance on pharmaceutical cocrystals as drug substance . The ... , The event follows the successful November 15th event that took place in ...
(Date:11/30/2016)... ... November 30, 2016 , ... On 28 November 2016, the International Union ... nihonium (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, ... earlier proposed by the discoverers have been approved by the IUPAC Bureau. The IUPAC ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... groundbreaking venture founded by Arianna Huffington, as part of the Thrive Global pop-up ... Explorer Kit, enabling purchasers to explore the microorganisms in their gut, collectively known ...
Breaking Biology Technology:
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):